Inventor · disambiguated record
Thomas R. Alessi
Also filed as: ALESSI THOMAS R
29 granted patents·10 pending applications·569 citations·filing 1987–2020
97Inventor score
Top patents by PatentIndex Score
39 records- 0199US7682356B2Osmotic delivery systems and piston assemblies for use thereinINTARCIA THERAPEUTICS INC·Filed 2007·Granted Mar 23, 2010·84 cites·22 claims
- 0296US9682127B2Osmotic delivery device comprising an insulinotropic peptide and uses thereofINTARCIA THERAPEUTICS INC·Filed 2016·Granted Jun 20, 2017·21 cites·30 claims
- 0396US8299025B2Suspension formulations of insulinotropic peptides and uses thereofALESSI THOMAS R·Filed 2008·Granted Oct 30, 2012·55 cites·16 claims
- 0496US7879028B2Osmotic delivery systems and piston assemblies for use thereinINTARCIA THERAPEUTICS INC·Filed 2010·Granted Feb 1, 2011·72 cites·16 claims
- 0595US9889085B1Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1cINTARCIA THERAPEUTICS INC·Filed 2015·Granted Feb 13, 2018·18 cites·23 claims
- 0695US8940316B2Osmotic delivery comprising an insulinotropic peptide and uses thereofALESSI THOMAS R·Filed 2010·Granted Jan 27, 2015·29 cites·15 claims
- 0795US8926595B2Devices, formulations, and methods for delivery of multiple beneficial agentsALESSI THOMAS R·Filed 2012·Granted Jan 6, 2015·31 cites·31 claims
- 0895US8298561B2Rapid establishment and/or termination of substantial steady-state drug deliveryALESSI THOMAS R·Filed 2010·Granted Oct 30, 2012·30 cites·14 claims
- 0994US9572889B2Devices, formulations, and methods for delivery of multiple beneficial agentsINTARCIA THERAPEUTICS INC·Filed 2014·Granted Feb 21, 2017·23 cites·63 claims
- 1094US8801700B2Osmotic delivery systems and piston assemblies for use thereinALESSI THOMAS R·Filed 2011·Granted Aug 12, 2014·46 cites·19 claims
- 1194US8343140B2Devices, formulations, and methods for delivery of multiple beneficial agentsINTARCIA THERAPEUTICS INC·Filed 2009·Granted Jan 1, 2013·30 cites·20 claims
- 1294US4895862ANovel benzyl-3H-1,2,3,5-oxathiadiazole 2-oxides useful as antihyperglycemic agentsAMERICAN HOME PROD·Filed 1989·Granted Jan 23, 1990·47 cites·17 claims
- 1392US4897405ANovel naphthalenylalkyl-3H-1,2,3,5-oxathiadiazole 2-oxides useful as antihyperglycemic agentsAMERICAN HOME PROD·Filed 1989·Granted Jan 30, 1990·62 cites·27 claims
- 1474US12042557B2Rapid establishment and/or termination of substantial steady-state drug deliveryINTARCIA THERAPEUTICS INC·Filed 2020·Granted Jul 23, 2024·0 cites·24 claims
- 1567US2010092566A1Highly concentrated drug particles, formulations, suspensions and uses thereofALESSI THOMAS R·Filed 2009·Application pending·0 cites
- 1666US10583080B2Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1cINTARCIA THERAPEUTICS INC·Filed 2018·Granted Mar 10, 2020·0 cites·27 claims
- 1766US2020360267A1THERAPEUTIC METHODS FOR THE TREATMENT OF DIABETES AND RELATED CONDITIONS FOR PATIENTS WITH HIGH BASELINE HbA1cINTARCIA THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1865US10441528B2Devices, formulations, and methods for delivery of multiple beneficial agentsINTARCIA THERAPEUTICS INC·Filed 2018·Granted Oct 15, 2019·0 cites·21 claims
- 1964US2020397690A1THERAPEUTIC METHODS FOR THE TREATMENT OF DIABETES AND RELATED CONDITIONS FOR PATIENTS WITH HIGH BASELINE HbA1cINTARCIA THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2063US10869830B2Rapid establishment and/or termination of substantial steady-state drug deliveryINTARCIA THERAPEUTICS INC·Filed 2018·Granted Dec 22, 2020·0 cites·21 claims
- 2163US10363287B2Method of manufacturing an osmotic delivery deviceINTARCIA THERAPEUTICS INC·Filed 2017·Granted Jul 30, 2019·0 cites·16 claims
- 2260US10231923B2Rapid establishment and/or termination of substantial steady-state drug deliveryINTARCIA THERAPEUTICS INC·Filed 2016·Granted Mar 19, 2019·0 cites·34 claims
- 2360US4786638A2,4-disubstituted-5-cyano-1,6-dihydro-6-oxo-1-pyrimidineacetic acid aldose reductase inhibitorsAMERICAN HOME PROD·Filed 1987·Granted Nov 22, 1988·4 cites·9 claims
- 2459US2013030417A1Rapid Establishment and/or Termination of Substantial Steady-State Drug DeliveryINTARCIA THERAPEUTICS INC·Filed 2012·Application pending·0 cites
- 2557US2012289944A1Highly concentrated drug particles, formulations, suspensions and uses thereofALESSI THOMAS R·Filed 2012·Application pending·0 cites
- 2657US2017079906A1Devices, formulations, and methods for delivery of multiple beneficial agentsINTARCIA THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 2756US2017119854A1Highly concentrated drug particles, formulations, suspensions and uses thereofINTARCIA THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 2855US10527170B2Osmotic delivery systems and piston assemblies for use thereinINTARCIA THERAPEUTICS INC·Filed 2014·Granted Jan 7, 2020·0 cites·12 claims
- 2953US4895860ANovel substituted 3H-1,2,3,5-oxathiadiazole 2-oxides useful as anthihyperglycemic agentsAMERICAN HOME PROD·Filed 1989·Granted Jan 23, 1990·3 cites·23 claims
- 3053US2015258016A1Osmotic delivery device comprising an insulinotropic peptide and uses thereofINTARCIA THERAPEUTICS INC·Filed 2015·Application pending·0 cites
- 3152US2016022582A1Highly concentrated drug particles, formulations, suspensions and uses thereofINTARCIA THERAPEUTICS INC·Filed 2015·Application pending·0 cites
- 3246US4966975AProcesses for the preparation of novel naphthalenylmethyl-3H-1,2,3,5-oxathiadiazole 2-oxides useful as antihyperglycemic agentsAMERICAN HOME PROD·Filed 1989·Granted Oct 30, 1990·2 cites·3 claims
- 3346US4786640A2,6-disubstituted-5-cyano-4-pyrimidinyloxyacetic acid aldose reductase inhibitorsAMERICAN HOME PROD·Filed 1987·Granted Nov 22, 1988·2 cites·7 claims
- 3445US11246913B2Suspension formulation comprising an insulinotropic peptideINTARCIA THERAPEUTICS INC·Filed 2019·Granted Feb 15, 2022·0 cites·17 claims
- 3543US4900829A2,4-disubstituted-5-cyano-1,6-dihydro-6-oxo-1-pyrimidineacetic acid aldose reductase inhibitorsAMERICAN HOME PROD·Filed 1988·Granted Feb 13, 1990·1 cites·1 claims
- 3640US4906753APreparation of 2,6-disubstituted-5-cyano-4-pyrimidinyloxyacetic acid aldose reductase inhibitorsAMERICAN HOME PROD·Filed 1988·Granted Mar 6, 1990·1 cites·1 claims
- 3740US4895861ANovel naphthalenyl-3H-1,2,3,5-oxathiadiazole 2-oxides useful as antihyperglycemic agentsAMERICAN HOME PROD·Filed 1989·Granted Jan 23, 1990·1 cites·16 claims
- 3835US5962523AMethods of using butyric acid derivatives to protect against hair lossDISCOVERY LAB INC·Filed 1996·Granted Oct 5, 1999·7 cites·18 claims
- 3934US2004242676A1Method of mitigating the adverse effects of IL-2Filed 2003·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Thomas R. Alessi files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →